Skip to main content
OpenTrials

Clinical trial condition

Breast Cancer

Explore clinical trials studying Breast Cancer. Study availability and eligibility vary by location and protocol.

6,546 public trials 1,158 recruiting studies
Refine in advanced search Browse all conditions

Breast Cancer trial results

Completed

Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer

NCT00097383

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. La Plata, Buenos Aires, Argentina
  • For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Rosario, Santa Fe Province, Argentina
  • For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Buenos Aires, Argentina
  • For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Ciudad de Buenos Aires, Argentina
View all 25 locations
View Trial Details
Completed

Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors

NCT00028405

Conditions
Adnexal Diseases, Anus Diseases, Anus Neoplasms, +54 more
Locations
  • University of Arizona, VA Medical Center Tucson, Arizona, United States
  • Detroit Medical Center, Wayne State University Detroit, Michigan, United States
  • East Carolina State University, Brody School of Medicine Greenville, North Carolina, United States
  • University of Pennsylvania School of Medicine Philadelphia, Pennsylvania, United States
View Trial Details
Completed

An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer

NCT00051779

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +14 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Bay Area Cancer Research Group Concord, California, United States
  • California Cancer Care, Inc. Greenbrae, California, United States
View all 38 locations
View Trial Details
Terminated

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-0587 as a Monotherapy and in Combination With Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer

NCT07214662

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • START - Midwest - EDOS Grand Rapids, Michigan, United States
  • START - San Antonio - EDOS San Antonio, Texas, United States
  • National Taiwan University Hospital Taipei, Taipei City, Taiwan
  • National Cheng Kung University Hospital Tainan, Taiwan
View Trial Details
Terminated

Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer

NCT07408089

Conditions
Advanced Breast Cancer, Breast Cancer, Breast Diseases, +6 more
Locations
  • The START Center for Cancer Research Los Angeles, California, United States
  • The START Center for Cancer Research Lake Success, New York, United States
  • NEXT Oncology Austin, Texas, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
View Trial Details

Related conditions